We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+3.87%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$4.81B
AUM Growth
-$531M
Cap. Flow
-$1.18B
Cap. Flow %
-24.44%
Top 10 Hldgs %
18.16%
Holding
673
New
167
Increased
91
Reduced
97
Closed
256

Top Buys

Rank Stock Value
1
CL icon
Colgate-Palmolive
CL
+$59.4M
2
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$56.3M
3
SPG icon
Simon Property Group
SPG
+$52M
4
TSM icon
TSMC
TSM
+$45.4M
5
M icon
Macy's
M
+$44.3M

Sector Composition

Rank Sector Weight
1 Real Estate 14.75%
2 Consumer Staples 11.78%
3 Consumer Discretionary 6.16%
4 Financials 6.01%
5 Industrials 5.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIFE
1
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$93.9M 1.95%
1,254,694
-15,411
-1% -$1.15M
PM icon
2
Philip Morris
PM
$293B
$88.1M 1.83%
1,017,968
+462,968
+83% +$40.5M
HUM icon
3
Humana
HUM
$44.1B
$81.6M 1.7%
874,175
+314,337
+56% +$28.8M
MSFT icon
4
Microsoft
MSFT
$3.71T
$64.6M 1.34%
1,938,838
+617,652
+47% +$20.3M
MDLZ icon
5
Mondelez International
MDLZ
$80.1B
$61.7M 1.28%
1,962,274
-607,727
-24% -$18.9M
ONXX
6
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$60.5M 1.26%
484,886
+444,886
+1,112% +$56.3M
CL icon
7
Colgate-Palmolive
CL
$74.1B
$59.4M 1.24%
+1,002,498
New +$59.4M
EL icon
8
Estee Lauder
EL
$30.9B
$58.7M 1.22%
840,359
-131,522
-14% -$8.91M
NLSN
9
DELISTED
Nielsen Holdings plc
NLSN
$53.8M 1.12%
1,475,842
+104,773
+8% +$3.6M
SPG icon
10
Simon Property Group
SPG
$71.9B
$49.9M 1.04%
+357,778
New +$52M
MHFI
11
DELISTED
MCGRAW-HILL FINANCIAL INC COM
MHFI
$46.6M 0.97%
711,160
+201,720
+40% +$12.2M
NE
12
DELISTED
Noble Corporation
NE
$45.7M 0.95%
1,384,240
-80,932
-6% -$2.75M
TSM icon
13
TSMC
TSM
$2.17T
$45.1M 0.94%
+2,660,700
New +$45.4M
ELN
14
DELISTED
ELAN CORP ADS(RP1 ORD4IRISH PN
ELN
$44.4M 0.92%
+2,850,000
New +$43M
DF
15
DELISTED
Dean Foods Company
DF
$41.9M 0.87%
2,168,498
+892,221
+70% +$18M
WMT icon
16
Walmart Inc
WMT
$892B
$41.7M 0.87%
1,692,174
-395,352
-19% -$9.97M
ASH icon
17
Ashland
ASH
$3.32B
$41.5M 0.86%
916,282
-400,645
-30% -$17.3M
WWAV
18
DELISTED
The WhiteWave Foods Company
WWAV
$41.2M 0.86%
2,064,413
+1,084,280
+111% +$20.6M
M icon
19
Macy's
M
$6.61B
$41M 0.85%
+947,899
New +$44.3M
BHP icon
20
BHP
BHP
$223B
$39.8M 0.83%
+706,960
New +$38.4M
ADBE icon
21
Adobe
ADBE
$103B
$39.7M 0.83%
765,000
+54,198
+8% +$2.59M
VTR icon
22
Ventas
VTR
$47.3B
$38.8M 0.81%
552,910
+91,360
+20% +$6.78M
MAA icon
23
Mid-America Apartment Communities
MAA
$15.5B
$38.5M 0.8%
616,133
+18,794
+3% +$1.21M
HOT
24
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$38M 0.79%
571,790
+350,221
+158% +$23.2M
KO icon
25
Coca-Cola
KO
$374B
$37.7M 0.78%
996,108
-591,582
-37% -$23.4M

Similar funds

UBS O'Connor's Q3 2013 Portfolio in Review

As of Q3 2013, UBS O'Connor held 673 positions worth $4.81B, down 9.9% from $5.34B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS O'Connor withdrew a net $1.18B in Q3 2013, closing 256 positions and reducing 97 holdings. Its most notable exit was Pfizer, an estimated $167M position sold in full.

By sector, the portfolio is most concentrated in Real Estate at 15% of assets, up from 13% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, UBS O'Connor opened a new position in Colgate-Palmolive worth $59.4M.

  • UBS O'Connor's largest Q3 2013 buy was Colgate-Palmolive: 1,002,498 shares worth $59.4M.
  • UBS O'Connor added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $56.3M increase.
  • UBS O'Connor's biggest Q3 2013 reduction was Advance Auto Parts, cutting an estimated $48.2M.
  • UBS O'Connor fully exited Pfizer in Q3 2013, selling an estimated $167M.
  • UBS O'Connor's ten largest holdings make up 18% of its $4.81B portfolio in Q3 2013.
  • UBS O'Connor opened 167 new positions and closed 256 in Q3 2013.
  • UBS O'Connor's portfolio value fell 9.9% quarter-over-quarter to $4.81B.

Based on UBS O'Connor's 13F filing for Q3 2013, filed 14 Nov 2013.